Identification of osteopontin as a novel marker for early hepatocellular carcinoma. - Wikidata - awgldk - TriplyDB

Identification of osteopontin as a novel marker for early hepatocellular carcinoma.

Identification of osteopontin as a novel marker for early hepatocellular carcinoma.

http://www.wikidata.org/entity/Q37557988

about

Role of Osteopontin in Liver Diseases Hepatocellular carcinoma: Review of disease and tumor biomarkers Controversies regarding and perspectives on clinical utility of biomarkers in hepatocellular carcinoma Role of biomarkers in the prediction and diagnosis of hepatocellular carcinoma Biomarkers for the early diagnosis of hepatocellular carcinoma Defining the extracellular matrix using proteomics Proteomic approaches to analyzing hepatitis C virus biology Identification of novel amelogenin-binding proteins by proteomics analysis Decreased expression of the Nkx2.8 gene correlates with tumor progression and a poor prognosis in HCC cancer.Osteopontin is up-regulated in chronic hepatitis C and is associated with cellular permissiveness for hepatitis C virus replication.The inhibitory effects of extracellular ATP on the growth of nasopharyngeal carcinoma cells via P2Y2 receptor and osteopontin.Small nucleolar RNA 113-1 suppresses tumorigenesis in hepatocellular carcinoma Hepatitis C virus network based classification of hepatocellular cirrhosis and carcinoma Molecular profiling of stroma identifies osteopontin as an independent predictor of poor prognosis in intrahepatic cholangiocarcinoma.Protein profiling in hepatocellular carcinoma by label-free quantitative proteomics in two west African populations The hepatitis B virus-associated tumor microenvironment in hepatocellular carcinoma.Recent developments in proteomic methods and disease biomarkers.Circulation long non-coding RNAs act as biomarkers for predicting tumorigenesis and metastasis in hepatocellular carcinoma Plasma osteopontin is a biomarker for the severity of alcoholic liver cirrhosis, not for hepatocellular carcinoma screening Prognostic significance of kynurenine 3-monooxygenase and effects on proliferation, migration, and invasion of human hepatocellular carcinoma.Two-Dimensional N-Glycan Distribution Mapping of Hepatocellular Carcinoma Tissues by MALDI-Imaging Mass Spectrometry.The impact of osteopontin on prognosis and clinicopathology of colorectal cancer patients: a systematic meta-analysis.Diagnostic Performance of Alpha-Fetoprotein, Protein Induced by Vitamin K Absence, Osteopontin, Dickkopf-1 and Its Combinations for Hepatocellular Carcinoma Screening for hepatocellular carcinoma and cholangiocarcinoma: Can biomarkers replace imaging?Defective Initiation of Liver Regeneration in Osteopontin-Deficient Mice after Partial Hepatectomy due to Insufficient Activation of IL-6/Stat3 Pathway Schistosome-induced cholangiocyte proliferation and osteopontin secretion correlate with fibrosis and portal hypertension in human and murine schistosomiasis mansoni.Midkine Increases Diagnostic Yield in AFP Negative and NASH-Related Hepatocellular Carcinoma.Elevated expression of UHRF1 predicts unfavorable prognosis for patients with hepatocellular carcinoma.Plasma osteopontin in acute liver failure.miR-21 Inhibition Reduces Liver Fibrosis and Prevents Tumor Development by Inducing Apoptosis of CD24+ Progenitor Cells Plasma Osteopontin Level in Chronic Liver Disease and Hepatocellular Carcinoma.Osteopontin and latent-TGF β binding-protein 2 as potential diagnostic markers for HBV-related hepatocellular carcinoma.CISD2 associated with proliferation indicates negative prognosis in patients with hepatocellular carcinoma Functional consequences of WNT3/Frizzled7-mediated signaling in non-transformed hepatic cells.Targeting late SV40 factor: is the achilles heel of hepatocarcinogenesis revealed?Osteopontin: A non-invasive parameter of portal hypertension and prognostic marker of cirrhosis.Hepatic stellate cells in liver development, regeneration, and cancer.Osteopontin promotes epithelial-mesenchymal transition of hepatocellular carcinoma through regulating vimentin Epidemiology and surveillance of hepatocellular carcinoma.The transcription factor c-JUN/AP-1 promotes HBV-related liver tumorigenesis in mice

P2860

Q26738504-E81E84BC-28D3-464E-9089-5067F9A9C209 Q26750796-6A37AD35-214E-4F86-AE70-1E46F83F9FE2 Q26772324-A9EAC4CD-EEE8-4BFC-8F5F-6ACEDD1DD351 Q26781469-3935FF41-2719-4B21-AE60-349CD62AD8DA Q26784418-7B0B1073-D966-4FF2-B80B-F381B6D0A875 Q26830221-EC8252C8-7E36-4744-9003-86026F609683 Q28085146-C9DBEF67-9A72-4AE8-AEF9-9E19DF1DAF48 Q31142421-AB08088F-22AC-4893-B9DE-ED94A8AABC2B Q33573050-5A1D8EAA-A244-44AC-AB61-7941509418A9 Q33746198-CE9C8318-8507-41B4-A24F-9F1EC90B0F62 Q33833150-BFA6A5B7-BC37-4961-AE1D-CC70A46D1431 Q34217385-3C08D8B0-AA86-4E5F-A5C7-AA523352D48A Q34228398-B1ACB625-39FD-403B-99E1-B70144ABCE5D Q34775377-E85B486E-E416-425B-8213-FAF3CBF2FB8B Q34918154-42D5C459-49CD-49CD-83E1-596BBCF17344 Q35136610-D4C2F9E5-50B1-4B23-A4DF-672F08C9B59E Q35197167-5B84EE0F-FA43-4B35-B391-C4EB72E1CCD3 Q35552063-5DA591DF-776E-488E-80AE-BA609EEBE82F Q35677840-9BBB62F3-5B3C-49A1-8B5C-3C59022C88A7 Q35775787-5C4EDE14-F0EF-4B68-B13A-C9A18C8373A4 Q35821161-A2EE824C-CC73-44C7-AE57-052584973967 Q35909530-E9080338-A99D-4BDB-9EF8-6E2FE2F1DA0D Q35960878-A5363994-B0B2-45DE-9D3F-227561A623B1 Q36000994-974D2FE2-E819-4EBE-95A2-22B42F2AD25C Q36002104-E4FBCDEF-E120-417F-B6DB-FEC5DD234397 Q36021605-E758CEDF-520C-4EB3-9DE3-25A39D21B6E2 Q36028022-BF7B3F68-8257-48B1-A818-4051D40C7383 Q36095316-07AA59AD-19CB-48EA-9EBC-336AD7EDEF69 Q36104218-84A7CCA9-EB56-4542-8ADC-7804DEED8B72 Q36154926-A29C1BB5-7B9A-4831-9D57-47A6B51E07CC Q36182332-5392CB41-051D-49CF-8857-9402A322AE6D Q36198665-92B5BB17-6C7D-4524-987A-06A876482550 Q36375646-ED258FB8-683D-4664-87E6-A2AF8CB10D5B Q36415111-8D608646-8C34-4971-B27F-90875EC9487E Q36460975-6D6B3291-42E6-4E47-9DA2-708D5DE0519C Q36724400-9C2F0374-78D6-4AE9-B8AF-CD56FF16DC7A Q36793474-30E53237-FD76-4622-91F3-8C3E5C9C6EF0 Q37022356-CC0D0306-72F6-42DB-926B-F956EF575965 Q37105532-70B4619A-2F1C-465F-BBBB-8887923A366E Q37179302-5D9AC9B9-6EDE-4403-9E0B-996799784CB3

P2860

Identification of osteopontin as a novel marker for early hepatocellular carcinoma.

http://www.wikidata.org/entity/Q37557988

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 19 December 2011

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Identification of osteopontin as a novel marker for early hepatocellular carcinoma.

@en

Identification of osteopontin as a novel marker for early hepatocellular carcinoma.

@nl

type

label

Identification of osteopontin as a novel marker for early hepatocellular carcinoma.

@en

Identification of osteopontin as a novel marker for early hepatocellular carcinoma.

@nl

prefLabel

Identification of osteopontin as a novel marker for early hepatocellular carcinoma.

@en

Identification of osteopontin as a novel marker for early hepatocellular carcinoma.

@nl

P1433

Q37557988-1655A3F4-EEE0-473D-9405-30F11461F8F3

P1476

Q37557988-2AFBBB7C-469B-4152-953E-10EB775CA36F

P2093

Q37557988-22FF058F-70CB-4376-9C36-49335C39013B

Q37557988-28D83E0B-D2CF-42ED-879C-5AFC88D797F3

Q37557988-485B7E07-3CCD-4274-BE9F-783EBD9B7254

Q37557988-807E08F0-3D6F-41F8-B1C2-27944B102E68

Q37557988-9A83114A-C8D1-412D-979E-6A7D39836F6A

Q37557988-AB867E1B-580F-42E2-9F9B-A2E8B64C0207

Q37557988-DCFB5A05-5925-4EB1-AA40-50E5528EABBF

P2860

Q37557988-177CD08A-B880-47F0-BEA7-3A05C7094FE7

Q37557988-244B0B27-6274-48E3-9911-395F0F692BF1

Q37557988-25DB26B2-1D19-4BBB-ADDC-60C196F56C76

Q37557988-3A675179-C868-4A77-B782-26DF5639F38D

Q37557988-3E797DFA-62C9-4E30-9FAE-0BAF77545579

Q37557988-443FCD8A-C701-412B-8285-60BCD5C16A81

Q37557988-45659111-18FC-4B3F-B912-44D9B10E66B3

Q37557988-4A7EDA95-2070-4DA4-836A-8C53FC382FFB

Q37557988-53DCD7ED-00AA-405D-8E25-E71A6BF8983E

Q37557988-68F9F424-7BD6-411F-B501-B571620E1AC0

P304

Q37557988-490277BE-3EA7-49DB-BA78-78FBE67DF040

P31

Q37557988-7980219A-7820-4661-BF5B-09098F133FAC

P356

Q37557988-CE75D3EF-5487-43B1-80FE-8F251CA6F071

P407

Q37557988-C58B1300-02DB-4802-A8E8-445742E31BAD

P433

Q37557988-9066ACA3-6DBD-4465-8467-050D9EDC947B

P478

Q37557988-BBA609B7-75E2-4143-8E91-A2252859B2F3

P50

Q37557988-46E5EA04-BCDC-4CC8-AD42-FD2BA8375092

Q37557988-A8889192-F266-4906-AD62-1EC93D46EDBB

P577

Q37557988-F31E7BA7-847B-4977-B952-CEAC36EAD8AA

P5875

Q37557988-55AF34B9-720D-4E71-B3D0-FF2126A96164

P698

Q37557988-8138BCDA-1BC3-46C7-A5EF-E6ED3965F9C5

P932

Q37557988-812737CC-34E2-445E-8828-98711792881C

P356

P1433

P1476

Identification of osteopontin as a novel marker for early hepatocellular carcinoma.

@en

P2093

Amelie Plymoth

http://www.w3.org/2001/XMLSchema#string

Hugo R Rosen

http://www.w3.org/2001/XMLSchema#string

Jorge A Marrero

http://www.w3.org/2001/XMLSchema#string

Laura Beretta

http://www.w3.org/2001/XMLSchema#string

Shaokui Ge

http://www.w3.org/2001/XMLSchema#string

Sufen Shang

http://www.w3.org/2001/XMLSchema#string

Ziding Feng

http://www.w3.org/2001/XMLSchema#string

P2860

Management of hepatocellular carcinoma

Present and future possibilities for early diagnosis of hepatocellular carcinoma

Des-gamma-carboxy prothrombin and alpha-fetoprotein as biomarkers for the early detection of hepatocellular carcinoma.

Phases of biomarker development for early detection of cancer.

The incidence and epidemiology of hepatocellular carcinoma: a global and regional perspective.

Mutations in TP53 and CTNNB1 in Relation to Hepatitis B and C Infections in Hepatocellular Carcinomas from Thailand

Issues in screening and surveillance for hepatocellular carcinoma.

Alpha-fetoprotein and ultrasonography screening for hepatocellular carcinoma.

Serum markers of hepatocellular carcinoma.

Non-alcoholic steatohepatitis and cancer.

P304

483-490

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/HEP.24703

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

55

http://www.w3.org/2001/XMLSchema#string

P50

Suleeporn Sangrajrang

P577

2011-12-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51667945

http://www.w3.org/2001/XMLSchema#string

P698

21953299

http://www.w3.org/2001/XMLSchema#string

P932

3914762

http://www.w3.org/2001/XMLSchema#string